National Registry of Evidence-Based Programs and Practices, 57742-57744 [2011-23757]
Download as PDF
<![CDATA[
57742
Federal Register / Vol. 76, No. 180 / Friday, September 16, 2011 / Notices
Matters To Be Considered
Summary Agenda
August 10, 2011 minutes—Open
Session.
(No substantive discussion of the
above items is anticipated. These
matters will be resolved with a single
vote unless a member of the ASC
requests that an item be moved to the
discussion agenda.)
Discussion Agenda
Appraisal Foundation May 2011 Grant
Reimbursement Request.
Appraisal Subcommittee Fiscal Year
2012 Budget.
How to Attend and Observe an ASC
Meeting
E-mail your name, organization and
contact information to meetings@asc.
gov.
You may also send a written request
via U.S. Mail, fax or commercial carrier
to the Executive Director of the ASC,
1401 H Street, NW., Ste. 760,
Washington, DC 20005. The fax number
is 202–289–4101. Your request must be
received no later than 4:30 p.m., ET, on
the Monday prior to the meeting.
Attendees must have a valid
government-issued photo ID and must
agree to submit to reasonable security
measures. The meeting space is
intended to accommodate public
attendees. However, if the space will not
accommodate all requests, the ASC may
refuse attendance on that reasonable
basis. The use of any video or audio
tape recording device, photographing
device, or any other electronic or
mechanical device designed for similar
purposes is prohibited at ASC meetings.
Dated: September 12, 2011.
James R. Park,
Executive Director.
[FR Doc. 2011–23876 Filed 9–15–11; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Registry of Evidence-Based
Programs and Practices
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice Regarding Substance
Abuse and Mental Health Services
Administration’s National Registry of
Evidence-based Programs and Practices
(NREPP): Open Submission Period for
Fiscal Year 2012.
mstockstill on DSK4VPTVN1PROD with NOTICES
AGENCY:
The mission of the Substance
Abuse and Mental Health Services
Administration (SAMHSA) is to reduce
SUMMARY:
VerDate Mar<15>2010
16:26 Sep 15, 2011
Jkt 223001
the impact of substance abuse and
mental illness on America’s
communities. Established in 1992, the
Agency was directed by Congress to
target effective substance abuse and
mental health services to the people
most in need, and to translate research
in these areas more effectively and more
rapidly into the general health care
system. The National Registry of
Evidence-based Programs and Practices
(NREPP) is a key public resource
SAMHSA has developed to help meet
this directive. This notice announces
NREPP’s open submission period for
Fiscal Year 2012, during which
developers of interventions may submit
an application for a potential review.
The notice explains how submissions
will be screened and selected, and
provides guidance on the submission
process. Potential applicants should be
aware that this notice includes updated
information relating to the eligibility of
interventions and the review process
that supersedes guidance provided in
earlier Federal Register notices.
FOR FURTHER INFORMATION CONTACT:
Kevin D. Hennessy, Ph.D., Science to
Service Coordinator, Center for
Behavioral Health Statistics and
Quality, SAMHSA, 1 Choke Cherry
Road, Room 2–1017, Rockville, MD
20857, telephone 240–276–2234.
Rose Shannon,
Director, Division of Executive
Correspondence.
Substance Abuse and Mental Health
Services Administration’s National
Registry of Evidence-Based Programs
and Practices (NREPP): Open
Submission Period for Fiscal Year 2012
Background
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) National Registry of
Evidence-based Programs and Practices
(NREPP) is a voluntary rating system
designed to provide the public with
reliable information about interventions
that promote mental health or prevent
or treat mental disorders, substance
abuse, substance use disorders, and/or
co-occurring disorders. Programs and
practices that are accepted for inclusion
in the registry undergo two independent
review processes in which their (1)
Quality of research and (2) readiness for
dissemination are evaluated and rated.
The results of these reviews are
published on the NREPP Web site
(https://nrepp.samhsa.gov).
It should be noted that inclusion in
NREPP does not constitute endorsement
of an intervention by SAMHSA.
Moreover, since NREPP has not
reviewed all interventions, the use of
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
NREPP as an exclusive or exhaustive list
of interventions is not appropriate.
Policymakers and funders in particular
are discouraged from limiting
contracted providers and/or potential
grantees to selecting only among NREPP
interventions.
This notice announces the next open
submission period during which
SAMHSA will consider and accept new
applications for review, describes the
minimum requirements and other
considerations that will be used in
screening and selecting interventions,
and provides guidance on the
submission process.
Dates of Open Submission Period
SAMHSA has established a 3-month
period for receipt of NREPP submissions
for Fiscal Year 2012 that will begin
November 1, 2011, and end February 1,
2012. Interventions submitted after
February 1, 2012, will not be considered
during this submission cycle. Program
developers, researchers, and others
interested in submitting an intervention
should read this notice for information
about current minimum requirements,
and examine the information provided
on the NREPP Web site about the review
process and criteria (https://
nrepp.samhsa.gov/Reviews.aspx) and
guidance for preparing an intervention
for submission (https://
nrepp.samhsa.gov/
SubmissionCourse.aspx). The selection
of interventions will take place after the
closing of the open submission period,
and applicants will be informed of their
acceptance status at that time. The
number of reviews conducted will
depend on the availability of funds,
with the final selection of interventions
and the timing of reviews to be
determined at the discretion of
SAMHSA.
In submitting an intervention,
applicants understand that the results of
NREPP reviews are considered public
information and will be posted on the
NREPP Web site. Once a review is
completed, the applicant will be
provided with a summary document
(‘‘intervention summary’’) that presents
ratings and descriptive information
about the intervention. Anyone that
consents to a review is expected to
authorize publication of the
intervention summary on the NREPP
Web site. If a summary is completed and
consent is not given to publish the
summary, a statement to that effect will
be posted on the NREPP Web site.
Applicants are encouraged to view
examples of NREPP intervention
summaries on the NREPP Web site to
become familiar with the end product of
the review process.
E:\FR\FM\16SEN1.SGM
16SEN1
Federal Register / Vol. 76, No. 180 / Friday, September 16, 2011 / Notices
Minimum Requirements
To be considered for review,
interventions must meet four minimum
requirements:
1. The intervention has produced one
or more positive behavioral outcomes (p
≤ .05) in mental health, mental
disorders, substance abuse, or substance
use disorders among individuals,
communities, or populations.
2. Evidence of these outcomes has
been demonstrated in at least one study
using an experimental or quasiexperimental design. Experimental
designs require random assignment, a
control or comparison group, and preand postintervention assessments.
Quasi-experimental designs do not
require random assignment, but do
require a comparison or control group
and pre- and postintervention
assessments; this category includes
longitudinal/multiple time series
designs with at least three
preintervention or baseline
measurements and at least three
postintervention or follow-up
measurements. Studies that are based on
single group, pre-/posttest designs do
not meet this requirement.
3. The results of these studies have
been published in a peer-reviewed
journal or other professional
publication, or documented in a
comprehensive evaluation report.
Comprehensive evaluation reports must
include a review of the literature,
theoretical framework, purpose,
57743
methodology, findings/results with
statistical analysis and p values for
significant outcomes, discussion, and
conclusions. Submissions must include
information that can be rated according
to the six Quality of Research criteria
identified on the NREPP Web site.
4. Implementation materials, training
and support resources, and quality
assurance procedures have been
developed and are ready for use by the
public.
Applicants are required to provide
documentation at the time of
submission that demonstrates the
intervention meets these minimum
requirements. Table 1 lists examples of
appropriate supporting documentation.
TABLE 1—DOCUMENTATION FOR DEMONSTRATING COMPLIANCE WITH MINIMUM REQUIREMENTS
Minimum requirement
Quality of Research ..........................
mstockstill on DSK4VPTVN1PROD with NOTICES
Readiness for Dissemination ............
Documentation
1. Intervention has produced one or more positive
behavioral outcomes (p ≤ .05) in mental health,
mental disorders, substance abuse, or substance
use disorders among individuals, communities, or
populations.
2. Evidence of these outcomes has been demonstrated in at least one study using an experimental or quasi-experimental design.
A list of significant behavioral outcomes that includes supporting citations (document/page number) for each outcome; and
3. Results of these studies have been published in
a peer-reviewed journal or other publication or
documented in a comprehensive evaluation report.
4. Implementation materials, training and support
resources, and quality assurance procedures
have been developed and are ready for use by
the public.
The following types of interventions
are not eligible for review and should
not be submitted to NREPP:
1. Stand-alone pharmacologic
treatments—The evidence base for
pharmacologic treatments is reviewed
and approved through the U.S. Food
and Drug Administration (FDA). FDAapproved pharmacotherapy
interventions (on-label use) are
considered for NREPP review only
when combined with one or more
behavioral or psychosocial treatments.
2. To remain consistent with
SAMHSA’s mission (‘‘to reduce the
impact of substance abuse and mental
illness on American communities’’),
NREPP will not accept for review, or
otherwise include on the NREPP Web
site, any interventions that have been
VerDate Mar<15>2010
16:26 Sep 15, 2011
Jkt 223001
A full-text copy of each article/report cited in the list
of outcomes. Other research articles, published
or unpublished evaluation reports, grant final reports, and replication studies may be submitted
as additional supporting documentation.
Note: Abstracts or URLs to partial articles are regarded as incomplete and will not be considered.
A brief narrative description and list of available
materials, resources, and systems to support implementation (e.g., treatment manuals, information for administrators, tested training curricula,
mechanisms for ongoing supervision and consultation, protocols for gathering process and outcome data, ongoing monitoring of intervention fidelity, processes for gathering feedback); and
A brief description of the method through which
new implementation sites acquire the above materials.
developed or evaluated with funds or
other support—either partially or
wholly—from organizations whose goals
or activities are determined to be
inconsistent with SAMHSA’s mission.
Selection of Interventions for Review
All submissions meeting the
minimum requirements will be
considered eligible for review. In
selecting interventions for review,
SAMHSA may choose to give special
consideration to interventions that meet
one or more of the following conditions:
• The original investigator(s) or an
independent party has used the same
protocol with an identical or similar
target population, and/or has used a
slightly modified protocol based on a
slightly modified population, where
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
results are consistent with positive
findings from the original evaluation.
• Implementation materials (e.g.,
program manuals, training guides,
measurement instruments,
implementation fidelity guides) are
available to the public at no cost.
• The intervention targets
underserved populations (e.g., minority
populations, elderly, young adults,
individuals who are incarcerated).
• The intervention contributes to a
content area where there are currently
limited evidence-based interventions.
Interventions that are not selected for
review may be resubmitted by the
applicant in a future open submission
period.
E:\FR\FM\16SEN1.SGM
16SEN1
57744
Federal Register / Vol. 76, No. 180 / Friday, September 16, 2011 / Notices
Instructions for Submitting an
Intervention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
To submit an intervention,
individuals should send a written
statement to NREPP expressing their
interest along with documentation that
demonstrates the intervention meets the
minimum requirements as described
above. All submissions must be made
either by a principal investigator (PI)
who has conducted research on the
intervention, a project director (PD) who
has worked with an evaluator of the
intervention, or a formally authorized
delegate of the PI or PD. For information
on where to submit materials, please
call 1–866–436–7377. Electronic
submissions are preferred, but materials
may be sent to NREPP in hard copy via
postal mail or fax. To be eligible for
consideration, submissions must be
received no later than 11:59 p.m. E.S.T.
on February 1, 2012; those received
before November 1, 2011, will be
disregarded.
For each intervention that is accepted,
the Principal (the individual, usually
the PI, formally designated as the
intervention’s point of contact and
decisionmaking authority during the
review process) will be asked to submit
additional documentation to be used in
the review. This additional
documentation includes full-text copies
of all articles and reports that provide
evidence of significant outcomes
(p ≤ .05) as well as copies of selected
dissemination materials in the format
they are provided to the public (e.g.,
hard copies or electronic versions of
manuals, training presentations, tools,
quality assurance protocols; URLs for
interactive Web-based resources).
The Principal continues to work with
NREPP staff throughout the review and
is responsible for approval of the final
intervention summary that is developed
by NREPP staff once the review has
been completed.
Centers for Disease Control and
Prevention
Contact Information
mstockstill on DSK4VPTVN1PROD with NOTICES
Individuals who have questions about
the information contained in this notice
may write to NREPP staff at
nrepp@samhsa.hhs.gov or call 1–866–
436–7377.
[FR Doc. 2011–23757 Filed 9–15–11; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
16:26 Sep 15, 2011
Jkt 223001
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Ethics
Subcommittee (ES)
Correction: This notice was published
in the Federal Register on September 8,
2011, Volume 76, Number 174, Page
55678. The correct time should be 1
p.m.–3:30 p.m.
Contact Person for More Information:
Drue Barrett, Ph.D., Designated Federal
Officer, ACD, CDC—ES, CDC, 1600
Clifton Road, NE., M/S D–50, Atlanta,
Georgia 30333. Telephone (404) 639–
4690. E-mail: dbarrett@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: September 12, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–23767 Filed 9–15–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10398]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
AGENCY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Generic
Clearance for Medicaid and CHIP State
Plan, Waiver, and Program Submissions;
Use: CMS is requesting a generic PRA
clearance for a body of forms necessary
to conduct ongoing business with State
partners in the implementation of
Medicaid and the Children’s Health
Insurance Program (CHIP). Examples of
the types of forms to be produced in this
collection include State plan
amendment templates, waiver and
demonstration templates, and reporting
templates. The development of
streamlined submission forms is critical
for States to implement timely health
reform initiatives in Medicaid and CHIP
state plans, demonstrations, and
waivers, including legislative
requirements enacted by the Affordable
Care Act. The development of
streamlined submissions forms
enhances the collaboration and
partnership between States and CMS by
documenting CMS policy for States to
use as they are developing program
changes. Streamlined forms improve
efficiency of administration by creating
a common and user-friendly
understanding of the information
needed by CMS to quickly process
requests for State plan amendments,
waivers, and demonstration, as well as
ongoing reporting.; Form Number:
CMS–10398 (OMB #0938–NEW);
Frequency: Occasionally; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
56; Total Annual Responses: 1120; Total
Annual Hours: 28,747. (For policy
questions regarding this collection
contact Candice Payne at 410–786–
4453. For all other issues call 410–786–
1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 76, Number 180 (Friday, September 16, 2011)]
[Notices]
[Pages 57742-57744]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23757]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Registry of Evidence-Based Programs and Practices
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice Regarding Substance Abuse and Mental Health Services
Administration's National Registry of Evidence-based Programs and
Practices (NREPP): Open Submission Period for Fiscal Year 2012.
-----------------------------------------------------------------------
SUMMARY: The mission of the Substance Abuse and Mental Health Services
Administration (SAMHSA) is to reduce the impact of substance abuse and
mental illness on America's communities. Established in 1992, the
Agency was directed by Congress to target effective substance abuse and
mental health services to the people most in need, and to translate
research in these areas more effectively and more rapidly into the
general health care system. The National Registry of Evidence-based
Programs and Practices (NREPP) is a key public resource SAMHSA has
developed to help meet this directive. This notice announces NREPP's
open submission period for Fiscal Year 2012, during which developers of
interventions may submit an application for a potential review. The
notice explains how submissions will be screened and selected, and
provides guidance on the submission process. Potential applicants
should be aware that this notice includes updated information relating
to the eligibility of interventions and the review process that
supersedes guidance provided in earlier Federal Register notices.
FOR FURTHER INFORMATION CONTACT: Kevin D. Hennessy, Ph.D., Science to
Service Coordinator, Center for Behavioral Health Statistics and
Quality, SAMHSA, 1 Choke Cherry Road, Room 2-1017, Rockville, MD 20857,
telephone 240-276-2234.
Rose Shannon,
Director, Division of Executive Correspondence.
Substance Abuse and Mental Health Services Administration's National
Registry of Evidence-Based Programs and Practices (NREPP): Open
Submission Period for Fiscal Year 2012
Background
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) National Registry of Evidence-based Programs and Practices
(NREPP) is a voluntary rating system designed to provide the public
with reliable information about interventions that promote mental
health or prevent or treat mental disorders, substance abuse, substance
use disorders, and/or co-occurring disorders. Programs and practices
that are accepted for inclusion in the registry undergo two independent
review processes in which their (1) Quality of research and (2)
readiness for dissemination are evaluated and rated. The results of
these reviews are published on the NREPP Web site (https://nrepp.samhsa.gov).
It should be noted that inclusion in NREPP does not constitute
endorsement of an intervention by SAMHSA. Moreover, since NREPP has not
reviewed all interventions, the use of NREPP as an exclusive or
exhaustive list of interventions is not appropriate. Policymakers and
funders in particular are discouraged from limiting contracted
providers and/or potential grantees to selecting only among NREPP
interventions.
This notice announces the next open submission period during which
SAMHSA will consider and accept new applications for review, describes
the minimum requirements and other considerations that will be used in
screening and selecting interventions, and provides guidance on the
submission process.
Dates of Open Submission Period
SAMHSA has established a 3-month period for receipt of NREPP
submissions for Fiscal Year 2012 that will begin November 1, 2011, and
end February 1, 2012. Interventions submitted after February 1, 2012,
will not be considered during this submission cycle. Program
developers, researchers, and others interested in submitting an
intervention should read this notice for information about current
minimum requirements, and examine the information provided on the NREPP
Web site about the review process and criteria (https://nrepp.samhsa.gov/Reviews.aspx) and guidance for preparing an
intervention for submission (https://nrepp.samhsa.gov/SubmissionCourse.aspx). The selection of interventions will take place
after the closing of the open submission period, and applicants will be
informed of their acceptance status at that time. The number of reviews
conducted will depend on the availability of funds, with the final
selection of interventions and the timing of reviews to be determined
at the discretion of SAMHSA.
In submitting an intervention, applicants understand that the
results of NREPP reviews are considered public information and will be
posted on the NREPP Web site. Once a review is completed, the applicant
will be provided with a summary document (``intervention summary'')
that presents ratings and descriptive information about the
intervention. Anyone that consents to a review is expected to authorize
publication of the intervention summary on the NREPP Web site. If a
summary is completed and consent is not given to publish the summary, a
statement to that effect will be posted on the NREPP Web site.
Applicants are encouraged to view examples of NREPP intervention
summaries on the NREPP Web site to become familiar with the end product
of the review process.
[[Page 57743]]
Minimum Requirements
To be considered for review, interventions must meet four minimum
requirements:
1. The intervention has produced one or more positive behavioral
outcomes (p <= .05) in mental health, mental disorders, substance
abuse, or substance use disorders among individuals, communities, or
populations.
2. Evidence of these outcomes has been demonstrated in at least one
study using an experimental or quasi-experimental design. Experimental
designs require random assignment, a control or comparison group, and
pre- and postintervention assessments. Quasi-experimental designs do
not require random assignment, but do require a comparison or control
group and pre- and postintervention assessments; this category includes
longitudinal/multiple time series designs with at least three
preintervention or baseline measurements and at least three
postintervention or follow-up measurements. Studies that are based on
single group, pre-/posttest designs do not meet this requirement.
3. The results of these studies have been published in a peer-
reviewed journal or other professional publication, or documented in a
comprehensive evaluation report. Comprehensive evaluation reports must
include a review of the literature, theoretical framework, purpose,
methodology, findings/results with statistical analysis and p values
for significant outcomes, discussion, and conclusions. Submissions must
include information that can be rated according to the six Quality of
Research criteria identified on the NREPP Web site.
4. Implementation materials, training and support resources, and
quality assurance procedures have been developed and are ready for use
by the public.
Applicants are required to provide documentation at the time of
submission that demonstrates the intervention meets these minimum
requirements. Table 1 lists examples of appropriate supporting
documentation.
Table 1--Documentation for Demonstrating Compliance With Minimum Requirements
----------------------------------------------------------------------------------------------------------------
Minimum requirement Documentation
----------------------------------------------------------------------------------------------------------------
Quality of Research................ 1. Intervention has produced one or A list of significant behavioral
more positive behavioral outcomes (p outcomes that includes supporting
<= .05) in mental health, mental citations (document/page number)
disorders, substance abuse, or for each outcome; and
substance use disorders among
individuals, communities, or
populations.
2. Evidence of these outcomes has A full-text copy of each article/
been demonstrated in at least one report cited in the list of
study using an experimental or quasi- outcomes. Other research articles,
experimental design. published or unpublished evaluation
reports, grant final reports, and
replication studies may be
submitted as additional supporting
documentation.
3. Results of these studies have been Note: Abstracts or URLs to partial
published in a peer-reviewed journal articles are regarded as incomplete
or other publication or documented and will not be considered.
in a comprehensive evaluation report.
Readiness for Dissemination........ 4. Implementation materials, training A brief narrative description and
and support resources, and quality list of available materials,
assurance procedures have been resources, and systems to support
developed and are ready for use by implementation (e.g., treatment
the public. manuals, information for
administrators, tested training
curricula, mechanisms for ongoing
supervision and consultation,
protocols for gathering process and
outcome data, ongoing monitoring of
intervention fidelity, processes
for gathering feedback); and
A brief description of the method
through which new implementation
sites acquire the above materials.
----------------------------------------------------------------------------------------------------------------
The following types of interventions are not eligible for review
and should not be submitted to NREPP:
1. Stand-alone pharmacologic treatments--The evidence base for
pharmacologic treatments is reviewed and approved through the U.S. Food
and Drug Administration (FDA). FDA-approved pharmacotherapy
interventions (on-label use) are considered for NREPP review only when
combined with one or more behavioral or psychosocial treatments.
2. To remain consistent with SAMHSA's mission (``to reduce the
impact of substance abuse and mental illness on American
communities''), NREPP will not accept for review, or otherwise include
on the NREPP Web site, any interventions that have been developed or
evaluated with funds or other support--either partially or wholly--from
organizations whose goals or activities are determined to be
inconsistent with SAMHSA's mission.
Selection of Interventions for Review
All submissions meeting the minimum requirements will be considered
eligible for review. In selecting interventions for review, SAMHSA may
choose to give special consideration to interventions that meet one or
more of the following conditions:
The original investigator(s) or an independent party has
used the same protocol with an identical or similar target population,
and/or has used a slightly modified protocol based on a slightly
modified population, where results are consistent with positive
findings from the original evaluation.
Implementation materials (e.g., program manuals, training
guides, measurement instruments, implementation fidelity guides) are
available to the public at no cost.
The intervention targets underserved populations (e.g.,
minority populations, elderly, young adults, individuals who are
incarcerated).
The intervention contributes to a content area where there
are currently limited evidence-based interventions.
Interventions that are not selected for review may be resubmitted
by the applicant in a future open submission period.
[[Page 57744]]
Instructions for Submitting an Intervention
To submit an intervention, individuals should send a written
statement to NREPP expressing their interest along with documentation
that demonstrates the intervention meets the minimum requirements as
described above. All submissions must be made either by a principal
investigator (PI) who has conducted research on the intervention, a
project director (PD) who has worked with an evaluator of the
intervention, or a formally authorized delegate of the PI or PD. For
information on where to submit materials, please call 1-866-436-7377.
Electronic submissions are preferred, but materials may be sent to
NREPP in hard copy via postal mail or fax. To be eligible for
consideration, submissions must be received no later than 11:59 p.m.
E.S.T. on February 1, 2012; those received before November 1, 2011,
will be disregarded.
For each intervention that is accepted, the Principal (the
individual, usually the PI, formally designated as the intervention's
point of contact and decisionmaking authority during the review
process) will be asked to submit additional documentation to be used in
the review. This additional documentation includes full-text copies of
all articles and reports that provide evidence of significant outcomes
(p <= .05) as well as copies of selected dissemination materials in the
format they are provided to the public (e.g., hard copies or electronic
versions of manuals, training presentations, tools, quality assurance
protocols; URLs for interactive Web-based resources).
The Principal continues to work with NREPP staff throughout the
review and is responsible for approval of the final intervention
summary that is developed by NREPP staff once the review has been
completed.
Contact Information
Individuals who have questions about the information contained in
this notice may write to NREPP staff at nrepp@samhsa.hhs.gov or call 1-
866-436-7377.
[FR Doc. 2011-23757 Filed 9-15-11; 8:45 am]
BILLING CODE 4160-01-P
